Angioplasty is one of the most common medical procedures in the U.S.; in 2006 more than 1.3 million were done.
Comparative effectiveness is about the new business environment facing medical products. A cornerstone of the Obama health plan is this benchmarking of treatments on the basis of risks, benefits and costs. In Europe, companies are entering into agreements where reimbursement is tied to comparative patient outcomes. In the U.S., comparative safety studies of Vioxx by payers sealed the fate of this multi-billion dollar product. How will all this impact innovation and new product development?
Comparative Effectiveness is part of Business Exchange, suggested by David O’Reilly. This topic contains 481 news and 1,017 blog items. Read updated news, blogs, and resources about Comparative Effectiveness. Find user-submitted articles and reactions on Comparative Effectiveness from like-minded professionals.
Other useful pages, Web sites and tools related to this topic.
Fifty-five year old David Jordan suffered a heart attack. His doctor suggests an angiogram to see if a blocked artery...
Consumer Reports publication based on comparative effectiveness research findings
A major comparative effectiveness study that shows some of the pros and cons of the field
Developing A Center For Comparative Effectiveness Information Gail R. Wilensky Interest in objective, credible...
Top Sources: Comparative Effectiveness
Please wait, content being added to topic...